[We must respect the anti-SARS-CoV-2 vaccine schedule without delay in cancer patients under treatment]

Bull Cancer. 2021 Apr;108(4):341-342. doi: 10.1016/j.bulcan.2021.02.003. Epub 2021 Mar 5.
[Article in French]
No abstract available

Publication types

  • Editorial

MeSH terms

  • Age Factors
  • COVID-19 / prevention & control*
  • COVID-19 Vaccines / administration & dosage*
  • COVID-19 Vaccines / immunology
  • COVID-19 Vaccines / supply & distribution
  • France
  • Humans
  • Immunization Programs
  • Immunization Schedule*
  • Immunization, Secondary
  • Immunocompromised Host
  • Neoplasms / immunology*
  • Neoplasms / psychology
  • Neoplasms / therapy
  • SARS-CoV-2

Substances

  • COVID-19 Vaccines